CN101797326A - 一种治疗肠鸣腹泻的中药制剂及其制备方法 - Google Patents
一种治疗肠鸣腹泻的中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN101797326A CN101797326A CN201010162137A CN201010162137A CN101797326A CN 101797326 A CN101797326 A CN 101797326A CN 201010162137 A CN201010162137 A CN 201010162137A CN 201010162137 A CN201010162137 A CN 201010162137A CN 101797326 A CN101797326 A CN 101797326A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine preparation
- borborygmus
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 102
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 title claims abstract description 53
- 206010012735 Diarrhoea Diseases 0.000 title abstract description 77
- 239000002398 materia medica Substances 0.000 title abstract description 10
- 235000006784 Saussurea lappa Nutrition 0.000 claims abstract description 16
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 15
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 14
- 244000268590 Euryale ferox Species 0.000 claims abstract description 14
- 241000206469 Pulsatilla Species 0.000 claims abstract description 3
- 241001180876 Saposhnikovia Species 0.000 claims abstract description 3
- 235000004879 dioscorea Nutrition 0.000 claims abstract description 3
- 239000003814 drug Substances 0.000 claims description 183
- 239000006187 pill Substances 0.000 claims description 57
- 239000003795 chemical substances by application Substances 0.000 claims description 52
- 235000012907 honey Nutrition 0.000 claims description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 38
- 210000000582 semen Anatomy 0.000 claims description 37
- 230000000741 diarrhetic effect Effects 0.000 claims description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000002775 capsule Substances 0.000 claims description 17
- 239000010271 massa medicata fermentata Substances 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 14
- 238000010438 heat treatment Methods 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 12
- 230000003203 everyday effect Effects 0.000 claims description 11
- 210000003038 endothelium Anatomy 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 8
- 229920002472 Starch Polymers 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000007924 injection Substances 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 6
- 239000006071 cream Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 239000002674 ointment Substances 0.000 claims description 4
- 235000011837 pasties Nutrition 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 206010013786 Dry skin Diseases 0.000 claims description 3
- -1 electuary Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 235000005903 Dioscorea Nutrition 0.000 claims description 2
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 2
- 241000498779 Myristica Species 0.000 claims description 2
- 241000219295 Portulaca Species 0.000 claims description 2
- 241000219780 Pueraria Species 0.000 claims description 2
- 241000405217 Viola <butterfly> Species 0.000 claims description 2
- 239000008298 dragée Substances 0.000 claims description 2
- 239000006196 drop Substances 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 239000011505 plaster Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 230000008719 thickening Effects 0.000 claims description 2
- 238000003809 water extraction Methods 0.000 claims description 2
- 241000234273 Dioscorea Species 0.000 claims 1
- 241001664510 Saussurea costus Species 0.000 claims 1
- 210000000952 spleen Anatomy 0.000 abstract description 87
- 210000002784 stomach Anatomy 0.000 abstract description 60
- 230000000694 effects Effects 0.000 abstract description 45
- 210000003734 kidney Anatomy 0.000 abstract description 36
- 208000002193 Pain Diseases 0.000 abstract description 32
- 210000004072 lung Anatomy 0.000 abstract description 29
- 210000004185 liver Anatomy 0.000 abstract description 20
- 244000272264 Saussurea lappa Species 0.000 abstract description 15
- 230000001105 regulatory effect Effects 0.000 abstract description 15
- 238000004519 manufacturing process Methods 0.000 abstract description 14
- 238000005728 strengthening Methods 0.000 abstract description 14
- 230000036528 appetite Effects 0.000 abstract description 11
- 235000019789 appetite Nutrition 0.000 abstract description 11
- 208000024891 symptom Diseases 0.000 abstract description 10
- 208000004998 Abdominal Pain Diseases 0.000 abstract description 7
- 208000008035 Back Pain Diseases 0.000 abstract description 7
- 230000001154 acute effect Effects 0.000 abstract description 6
- 208000008930 Low Back Pain Diseases 0.000 abstract description 5
- 235000013399 edible fruits Nutrition 0.000 abstract description 5
- 230000001914 calming effect Effects 0.000 abstract description 4
- 208000021735 chronic enteritis Diseases 0.000 abstract description 4
- 208000013403 hyperactivity Diseases 0.000 abstract description 4
- 208000012876 acute enteritis Diseases 0.000 abstract description 3
- 206010000060 Abdominal distension Diseases 0.000 abstract description 2
- 244000270834 Myristica fragrans Species 0.000 abstract description 2
- 235000009421 Myristica fragrans Nutrition 0.000 abstract description 2
- 230000009467 reduction Effects 0.000 abstract description 2
- 230000003867 tiredness Effects 0.000 abstract description 2
- 208000016255 tiredness Diseases 0.000 abstract description 2
- 206010000084 Abdominal pain lower Diseases 0.000 abstract 1
- 241000304531 Allium macrostemon Species 0.000 abstract 1
- 244000080767 Areca catechu Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 240000007371 Cuscuta campestris Species 0.000 abstract 1
- 241000099774 Cuscuta salina Species 0.000 abstract 1
- 240000005717 Dioscorea alata Species 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 208000006083 Hypokinesia Diseases 0.000 abstract 1
- 241001673966 Magnolia officinalis Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 241000405911 Rehmannia glutinosa Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 206010057040 Temperature intolerance Diseases 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 239000001702 nutmeg Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 55
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 40
- 230000000968 intestinal effect Effects 0.000 description 37
- 201000010099 disease Diseases 0.000 description 36
- 238000012360 testing method Methods 0.000 description 32
- 210000004369 blood Anatomy 0.000 description 26
- 239000008280 blood Substances 0.000 description 26
- 208000001848 dysentery Diseases 0.000 description 24
- 230000007812 deficiency Effects 0.000 description 22
- 230000029087 digestion Effects 0.000 description 20
- 230000001737 promoting effect Effects 0.000 description 20
- 241001465754 Metazoa Species 0.000 description 18
- 230000001142 anti-diarrhea Effects 0.000 description 18
- 230000006870 function Effects 0.000 description 18
- 210000002700 urine Anatomy 0.000 description 18
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 17
- 241000699670 Mus sp. Species 0.000 description 17
- 230000033001 locomotion Effects 0.000 description 17
- 235000013305 food Nutrition 0.000 description 16
- 206010047700 Vomiting Diseases 0.000 description 15
- 239000007789 gas Substances 0.000 description 15
- 230000003014 reinforcing effect Effects 0.000 description 14
- 206010000087 Abdominal pain upper Diseases 0.000 description 13
- 210000000936 intestine Anatomy 0.000 description 13
- 239000009806 pulsatillae Substances 0.000 description 13
- 230000008673 vomiting Effects 0.000 description 13
- 206010011224 Cough Diseases 0.000 description 12
- 210000001015 abdomen Anatomy 0.000 description 12
- 201000006549 dyspepsia Diseases 0.000 description 12
- 230000001717 pathogenic effect Effects 0.000 description 12
- 239000000725 suspension Substances 0.000 description 12
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 11
- 230000037396 body weight Effects 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 11
- 239000012153 distilled water Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 230000035922 thirst Effects 0.000 description 11
- 241000700159 Rattus Species 0.000 description 10
- 230000001276 controlling effect Effects 0.000 description 10
- 239000000976 ink Substances 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 9
- 208000000059 Dyspnea Diseases 0.000 description 9
- 206010013975 Dyspnoeas Diseases 0.000 description 9
- 206010030113 Oedema Diseases 0.000 description 9
- 208000019790 abdominal distention Diseases 0.000 description 9
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical group O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 9
- 210000001124 body fluid Anatomy 0.000 description 9
- 239000010839 body fluid Substances 0.000 description 9
- 210000002429 large intestine Anatomy 0.000 description 9
- 210000000813 small intestine Anatomy 0.000 description 9
- 239000004382 Amylase Substances 0.000 description 8
- 108010065511 Amylases Proteins 0.000 description 8
- 102000013142 Amylases Human genes 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 235000019418 amylase Nutrition 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 239000003610 charcoal Substances 0.000 description 8
- 208000019902 chronic diarrheal disease Diseases 0.000 description 8
- 230000014759 maintenance of location Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 8
- 206010019705 Hepatic pain Diseases 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 206010037660 Pyrexia Diseases 0.000 description 7
- 230000002411 adverse Effects 0.000 description 7
- 206010061428 decreased appetite Diseases 0.000 description 7
- 230000002496 gastric effect Effects 0.000 description 7
- 230000027939 micturition Effects 0.000 description 7
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 7
- 244000052769 pathogen Species 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 6
- 208000004232 Enteritis Diseases 0.000 description 6
- 206010033557 Palpitations Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 210000000481 breast Anatomy 0.000 description 6
- 235000013339 cereals Nutrition 0.000 description 6
- 206010009887 colitis Diseases 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 238000003304 gavage Methods 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 206010022437 insomnia Diseases 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 238000010791 quenching Methods 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 5
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 5
- 208000022531 anorexia Diseases 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 229940088710 antibiotic agent Drugs 0.000 description 5
- 238000002651 drug therapy Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 210000003414 extremity Anatomy 0.000 description 5
- 239000010135 fructus aurantii immaturus Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 235000013372 meat Nutrition 0.000 description 5
- 239000012567 medical material Substances 0.000 description 5
- 230000002269 spontaneous effect Effects 0.000 description 5
- 230000001502 supplementing effect Effects 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 206010017553 Furuncle Diseases 0.000 description 4
- 206010059013 Nocturnal emission Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 239000007900 aqueous suspension Substances 0.000 description 4
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 4
- 229940093265 berberine Drugs 0.000 description 4
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 208000013116 chronic cough Diseases 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 230000006735 deficit Effects 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 201000001881 impotence Diseases 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 210000003097 mucus Anatomy 0.000 description 4
- 210000001187 pylorus Anatomy 0.000 description 4
- 229910021647 smectite Inorganic materials 0.000 description 4
- 230000004206 stomach function Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 208000008967 Enuresis Diseases 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010061245 Internal injury Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 206010030302 Oliguria Diseases 0.000 description 3
- 206010057071 Rectal tenesmus Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000004596 appetite loss Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 230000001605 fetal effect Effects 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 235000012631 food intake Nutrition 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 208000019017 loss of appetite Diseases 0.000 description 3
- 235000021266 loss of appetite Nutrition 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- ALWKGYPQUAPLQC-UHFFFAOYSA-N neostigmine Chemical compound CN(C)C(=O)OC1=CC=CC([N+](C)(C)C)=C1 ALWKGYPQUAPLQC-UHFFFAOYSA-N 0.000 description 3
- 229960002362 neostigmine Drugs 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 230000001141 propulsive effect Effects 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 208000012271 tenesmus Diseases 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 208000008710 Amebic Dysentery Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010001986 Amoebic dysentery Diseases 0.000 description 2
- 229930003347 Atropine Natural products 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- VKJGBAJNNALVAV-UHFFFAOYSA-M Berberine chloride (TN) Chemical compound [Cl-].C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 VKJGBAJNNALVAV-UHFFFAOYSA-M 0.000 description 2
- 208000031648 Body Weight Changes Diseases 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 206010008631 Cholera Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- 208000014540 Functional gastrointestinal disease Diseases 0.000 description 2
- 241000123871 Gueldenstaedtia verna Species 0.000 description 2
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020710 Hyperphagia Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 206010024642 Listless Diseases 0.000 description 2
- 208000019693 Lung disease Diseases 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 206010000059 abdominal discomfort Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 229960000396 atropine Drugs 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 238000012742 biochemical analysis Methods 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 230000004579 body weight change Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- DCSUBABJRXZOMT-IRLDBZIGSA-N cisapride Chemical compound C([C@@H]([C@@H](CC1)NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)OC)N1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-IRLDBZIGSA-N 0.000 description 2
- 229960005132 cisapride Drugs 0.000 description 2
- DCSUBABJRXZOMT-UHFFFAOYSA-N cisapride Natural products C1CC(NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)C(OC)CN1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-UHFFFAOYSA-N 0.000 description 2
- 239000000571 coke Substances 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 102000038379 digestive enzymes Human genes 0.000 description 2
- 108091007734 digestive enzymes Proteins 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- FGXWKSZFVQUSTL-UHFFFAOYSA-N domperidone Chemical compound C12=CC=CC=C2NC(=O)N1CCCN(CC1)CCC1N1C2=CC=C(Cl)C=C2NC1=O FGXWKSZFVQUSTL-UHFFFAOYSA-N 0.000 description 2
- 229960001253 domperidone Drugs 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 230000007937 eating Effects 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000002489 hematologic effect Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 150000002630 limonoids Chemical class 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 210000000713 mesentery Anatomy 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 238000009527 percussion Methods 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000001671 psychotherapy Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000001995 reticulocyte Anatomy 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- 206010000050 Abdominal adhesions Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 239000008589 Cortex Fraxini Substances 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 244000281702 Dioscorea villosa Species 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010064147 Gastrointestinal inflammation Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 241001071804 Gentianaceae Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020651 Hyperkinesia Diseases 0.000 description 1
- 208000000269 Hyperkinesis Diseases 0.000 description 1
- 208000008017 Hypohidrosis Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 208000005168 Intussusception Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 244000021150 Orbignya martiana Species 0.000 description 1
- 235000014643 Orbignya martiana Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 206010034647 Peristalsis visible Diseases 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010041954 Starvation Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241000244155 Taenia Species 0.000 description 1
- 240000006688 Telosma cordata Species 0.000 description 1
- 235000017352 Telosma cordata Nutrition 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 241001106476 Violaceae Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047697 Volvulus Diseases 0.000 description 1
- HOBWAPHTEJGALG-JKCMADFCSA-N [(1r,5s)-8-methyl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate;sulfate Chemical compound [O-]S([O-])(=O)=O.C([C@H]1CC[C@@H](C2)[NH+]1C)C2OC(=O)C(CO)C1=CC=CC=C1.C([C@H]1CC[C@@H](C2)[NH+]1C)C2OC(=O)C(CO)C1=CC=CC=C1 HOBWAPHTEJGALG-JKCMADFCSA-N 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 206010002512 anhidrosis Diseases 0.000 description 1
- 230000037001 anhydrosis Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 229960002028 atropine sulfate Drugs 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 208000012408 autosomal dominant progressive nephropathy with hypertension Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000027687 belching Diseases 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 201000007637 bowel dysfunction Diseases 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 235000021551 crystal sugar Nutrition 0.000 description 1
- 239000008912 dachengqi decoction Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical group O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 230000002478 diastatic effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003866 digestant Substances 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 208000008025 hordeolum Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 201000007772 internal hemorrhoid Diseases 0.000 description 1
- 201000006334 interstitial nephritis Diseases 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 201000007647 intestinal volvulus Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000010112 ling-gui-zhu-gan decoction Substances 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000001809 melena Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 150000002772 monosaccharides Chemical group 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940127249 oral antibiotic Drugs 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 238000002579 sigmoidoscopy Methods 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 208000016303 spleen symptom Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000005494 tarnishing Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000005090 tracheal smooth muscle Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 208000022534 visible peristalsis Diseases 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 235000011844 whole wheat flour Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗肠鸣腹泻的中药制剂及其制备方法。中药制剂各种组份为:白头翁,山药,炒芡实,马齿苋,云木香,肉豆蔻,白术,茯苓,地丁,薤白,大腹皮,黄连,陈皮。当伴腰痛、畏寒、少腹冷痛、晨起即泻明显者加肉桂,菟丝子,五味子,熟地;伴明显腹痛、腹胀,泻后痛减者加厚朴,枳壳,白芍,葛根,防风;伴纳差不食、食而不化者加焦三仙,鸡内金。本发明的中药制剂具有平肝止痛、理气健脾、补脾肺肾、补中益气和升阳止泻的功效,主治急慢性肠炎和结肠炎,肝旺和脾胃虚弱引起的肠鸣腹泻、食少便溏、肢倦乏力、泻后痛缓和反复发作等症。且配方简单,制造成本低廉,可推广使用。
Description
技术领域
本发明涉及含有来源于植物、动物或矿物组份的医用配制品,特别涉及一种治疗肠鸣腹泻的中药制剂。
背景技术
临床上凡是肠扭转、肠套迭、肠粘连、肠肿瘤、肠道蛔虫梗阻等疾病,造成肠子竭尽全力地拼命蠕动,企图重新沟通肠道,因而肠鸣音亢进现象便接踵而至。当肠内菌群失调,使各种细菌在肠内发酵,产生了大量的气体,使得胃肠内内容物产生幅度过大,或超出常规的移动,所以就会出现肠鸣。也就是通常所说的肠鸣音亢进。
一般人饿了肚子会呱呱叫都是正常的,但是如果出现肠鸣音次数有显著增多,每分钟达15次以上,音响明显增大,有时会出现“气过水声”,仿佛有股气流在水面上冲击而过时发出的声音,那就叫做肠鸣音亢进。对于肠鸣严重的患者甚至会出现犹如金属撞击般的叮铃声或金属声。随着肠鸣音的亢进,病人会出现一阵阵剧烈腹痛,腹部也可见到肠子成段状般地隆起,医学上称作为“肠型”。肠鸣音亢进是机械性肠梗阻的强烈“信号”。
一般肠鸣都是由于肠内菌群失调引起,因为使各种细菌在肠内发酵,产生了大量的气体,使得胃肠内内容物产生幅度过大,或超出常规的移动,所以就会出现肠鸣。但是并存诸多症状,且发作时间累计一月以上者。就预示肠炎、胃炎的存在。这类患者较容易出现消化不良,不能充分吸收营养,一方面造成营养的流失和必须营养的供给,势必给正常的生理需求造成较大的危害。尤其是女士和中老年朋友,一旦出现类似病情,轻则营养不良,重则脱水,引发失眠,肤色暗黄,消瘦,慢性病急性发作或加重病情。连续3月者,较容易导致恶性循环的胃肠炎症。
若肠鸣表现单独存在,其病因主要是消化不良。肠道产气过多,且不能顺畅循环。危害性较小。治疗上主要以收敛药或调理药物为主。平时别吃太多的肉、高蛋白的食物,多运动。多吃新鲜蔬菜、水果。对于成年人的肠鸣,当肠内菌群失调,使各种细菌尤其是有害菌在肠内发酵,产生了大量的气体,使得胃肠内内容物产生幅度过大,或超出常规的移动,所以就会出现肠鸣。也就是通常所说的肠亢进。
所以,增加体内有益菌,抑制有害菌的生长才是根本。肠炎的症状很多,肠鸣大多不会单独存在。较多情况下是和腹胀、肠功能紊乱、腹痛等很多症状并存,患者一定要早发现早治疗。临床还较多伴随出现腹痛、腹泻、便秘等消化系统症状。其起因是胃肠道功能紊乱。当患者出现焦虑、精神压抑等心理异常,各种精神性疾病如忧郁,癔病时也伴随出现肠鸣腹泻的症状。随着人们生活节奏的加快,此病呈上升的趋势。
目前采用的治疗方法主要有心理治疗,饮食治疗和药物治疗。由于现代医学对于其病理学以及发病机制仍未明确,使得化学药品治疗陷入被动。目前上市的化学药品虽、具疗效,常伴一定的副作用,使得心理治疗在本病的治疗中占有很重要的地位。
中医认为,肠鸣腹泻多属于“五更泄”、“久痢”范畴。目前治疗此症,西医一般都采用注射抗生素和有益菌类,根治率低,易复发,且易产生副作用;西药治疗相应的疾病,主要以思密达、吗丁啉、西沙必利、阿洛斯琼等为主,仅仅是针对肠鸣、腹泻的表症加以治疗,没有深挖细揪,没有建立在整体调理,身心兼治的前提下,所以疗效一般,长期服用还能产生让医生和病人均担忧的副作用。中成药常用补脾益肠丸、结肠炎丸和肠胃宁胶囊等,效果也不是很理想。中医认为其病机是由于脾肾阳虚,脾胃虚弱,肝气犯胃,饮食无度和寒湿暑热外邪伤脾等,因此应平肝止痛、理气健脾、补脾肺肾、补中益气和升阳止泻,方能治愈此类疾病。
发明内容
本发明所要解决的技术问题在于,提供一种配方简单、制作工艺简便的治疗肠鸣腹泻的中药制剂及其制备方法,平肝止痛、理气健脾、补脾肺肾、补中益气和升阳止泻,能够很好的治愈肠鸣腹泻类疾病。
为解决上述技术问题,本发明提供一种治疗肠鸣腹泻的中药制剂,各种组份的重量份数比为:白头翁10~20份,山药10~20份,炒芡实10~20份,马齿苋10~15份,云木香10~20份,肉豆蔻10~20份,白术10~20份,茯苓10~20份,地丁10~20份,薤白10~20份,大腹皮10~20份,黄连10~15份,陈皮10~20份。
所述治疗肠鸣腹泻的中药制剂,当病患伴腰痛、畏寒、少腹冷痛、晨起即泻明显者可以在组方中加入肉桂10~20份,菟丝子10~20份,五味子10~20份,熟地10~20份。
所述治疗肠鸣腹泻的中药制剂,当病患伴明显腹痛、腹胀,泻后痛减者可以在组方中加厚朴10~20份,枳壳10~20份,白芍10~20份,葛根10~20份,防风10~20份。
所述治疗肠鸣腹泻的中药制剂,当病患伴纳差不食、食而不化者可以在组方中加焦三仙各10份,鸡内金10~15份。
所述治疗肠鸣腹泻的中药制剂的剂型可以为:片剂、糖衣片剂、薄膜衣片剂、肠溶衣片剂、胶囊剂、硬胶囊剂、软胶囊剂、口服液、口含剂、颗粒剂、冲剂、丸剂、散剂、膏剂、丹剂、混悬剂、溶液剂、注射剂、栓剂、软膏剂、硬膏剂、霜剂、喷雾剂、滴剂或贴剂。
所述治疗肠鸣腹泻的中药制剂,其剂型为胶囊剂的制备方法包括:a称取组份药材加入水提取2次,成浸膏状,为组分1;
b药渣加乙醇浓缩过滤为浸膏状,为组分2;
c将上述两种浸膏浓缩干燥成干膏,混合粉碎,加淀粉适量,混匀,灌装胶囊。
所述步骤a中,称取组份药材可以加入5-10倍量的水浸泡1-2小时,提取2次;加热提取1-2小时,浓缩至浸膏状,成为组分1。
所述步骤b中,药渣可以加60-90%乙醇浸泡0.5-1.5小时,提取两次,每次1-2小时,合并提取液,滤过,浓缩,80-160目滤过,6000-10000转/分钟离心后的上清液,经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为1.35(80℃)的浸膏,加热回流提取2次,每次30分钟~45分钟,提取活性成份,将2次提取液合并静置成浸膏状,作为组分2。
所述治疗肠鸣腹泻的中药制剂,其剂型为蜜丸剂的制备方法包括:
将所述中药制剂的组份药材加水浸泡30分钟至1小时,加热煮沸30~40分钟,过滤,滤液备用;滤渣加水第二次加热,煮沸30~40分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸30~40分钟,过滤;将三次滤液合在一起,加热浓缩至糊状,放入烘箱70℃~80℃烘干后冷却,烘干后冷却,与蜂蜜混在一起搓成细条;以5g为一丸腊封包装。
所述治疗肠鸣腹泻的中药制剂,在使用时煎汤剂服用,可以每日1剂,水煎分两次服,每7天为一疗程;当本中药制剂为丸剂、胶囊剂或片剂使用时,可以一日三次,每10天为一疗程。
本发明肠鸣腹泻的中药制剂具有平肝止痛、理气健脾、补脾肺肾、补中益气和升阳止泻的功效,主治急慢性肠炎和结肠炎,肝旺和脾胃虚弱引起的肠鸣腹泻、食少便溏、肢倦乏力、泻后痛缓和反复发作等症。
具体实施方式
中医认为,肠炎属于“五更泄”、“久痢”范畴。目前治疗肠鸣腹泻,西医一般都采用注射抗生素和有益菌类,根治率低,易复发,且易产生副作用;中成药常用补脾益肠丸、结肠炎丸和肠胃宁胶囊等,效果也不是很理想。中医认为其病机是由于脾肾阳虚,脾胃虚弱,肝气犯胃,饮食无度和寒湿暑热外邪伤脾等,因此应平肝止痛、理气健脾、补脾肺肾、补中益气和升阳止泻,方能治愈此类疾病。经过临床观察,本发明的发明人发现本中药制剂对于肠鸣腹泻,急慢性肠炎和结肠炎等症具有极佳的治疗效果,减轻了各种不适的症状,同时未发现不良反应。中医学认为肠鸣腹泻系肝气郁结,脾失健运所致。肝主疏泄,喜条达,脾胃素虚,复因心情不遂,忧思恼怒,精神紧张,以致肝气郁结,气机不畅,失其条达,横逆乘脾,而致运化传导失常,呈现腹痛泄泻等症。《景岳全书》引刘草窗方,方由白术、白芍、陈皮和防风四味组成;《金匮要略》中也提供了用白术、白芍、陈皮和防风四味药物治疗“痛泻症”的方案。四药相配,可以补脾土而泻肝木,调气机以止痛泻。用于治疗肠鸣腹泻,大便泻泄,泻后腹痛诸症。但是以上古方的药物均采用炮制过的熟药,特别是白术、白芍、陈皮均为“炙”品。
西药治疗相应的疾病,主要以思密达、吗丁啉、西沙必利、阿洛斯琼等为主,仅仅是针对腹痛、腹泻的表症加以治疗,没有深挖细揪,没有建立在整体调理,身心兼治的前提下,所以疗效一般,长期服用还能产生让医生和病人均担忧的副作用。本发明所阐述的药物不但能治疗身体的痛苦,还能调节心理的病痛,长期服用没有毒副作用,原材料价廉质优易得。白术能补气健脾和燥湿利水,用于脾胃虚寒之腹满泄泻;白芍能平肝止痛和敛阴止汗,用于肝脾不调、腹痛泄泻等;茯苓能利水渗湿和健脾安神,用于脾虚泄泻;山药能益气养阴和补脾肺肾。用于脾胃虚弱和止泻等;陈皮能理气健脾,用于肝气乘脾,腹痛泄泻等;芡实,云木香能敛肺滋肾和涩精止泻,用于久泻不止;葛根,地丁能生津止渴和升阳止泻;诸药配伍,共奏清热解毒、疏散风热、利咽消肿和滋阴润肺之效。方中白头翁,马齿苋,益气敛阴,助补气生阴之力;白术滋阴润燥、清热除烦;茯苓,补脾益肾,载药上行,薤白,大腹皮,厚朴使药力上行,可行气血,使诸药滋而不腻,补不留瘀;枳壳化瘀除湿;陈皮开胃消食,葛根清热消烦,焦三仙和鸡内金健脾消食,是治疗厌食,积食的良药。
白头翁味苦,性寒;归胃、大肠经;具有清热解毒,凉血止痢,燥湿杀虫的功效;主治热毒痢疾,鼻衄,血痔,带下,阴痒,痈疮,瘰疬白头翁为治阿米巴痢疾的要药,单用较大剂量,即有效果。常用成方白头翁汤,即以本品为主药,配合黄连、黄柏、秦皮而成,既可用治阿米巴痢疾,也可用治菌痢。《本草正义》载其:白头翁味微苦而淡,气清质轻,《本经》虽谓苦温,然以主治温疟狂易,而仲景且以专治热利下重,则必非温药可知。其主热毒滞下,虽曰苦固能泄,而升举脾胃清气,使不陷下,则里急后重皆除,确是此药之实在真谛。
马齿苋味酸;性寒清热解毒;凉血止痢;除湿通淋。该品有清热解毒、祛湿止带功效,适用于湿热下注、带下色黄、黏稠味臭、小便短黄、口渴口苦、舌红苔黄、脉滑者,亦可用于湿热泄泻、痢疾等。
云木香别名木香、广木香,为菊科植物云木香(Aucklandia lappaDecne.),以根入药。药性辛、苦,温。归脾、胃、大肠、三焦、胆经。行气止痛,健脾消食。用于胸脘胀痛,泻痢后重,食积不消,不思饮食。云木香实肠止泻。用于泄泻腹痛。对胃肠道有兴奋或抑制双向作用,有促进消化液分泌、利胆、松弛气管平滑肌、抑菌、利尿、等作用。
薤白辛、苦,温。归肺、胃、大肠经。理气,宽胸,通阳,散结。治胸痹心痛彻背,脘痞不舒,干呕,泻痢后重,疮疖。通阳散结,行气导滞。用于胸痹疼痛,痰饮咳喘,泄痢后重。《本草拾遗》载其:调中,主久利不瘥,大腹内常恶者,但多煮食之。
大腹皮为棕榈科植物槟榔的干燥果皮,又名槟榔衣。主产于海南、广西、云南等地。冬季至次春采收未成熟的果实,煮后干燥,纵剖两瓣,剥取果皮,习称“大腹皮”。味辛;性微温。归脾;胃;大肠;小肠经。现代研究,该品有兴奋胃肠道平滑肌、促胃肠动力作用,并有促进纤维蛋白溶解等作用。《开宝本草》:主冷热气攻心腹,大肠壅毒,痰膈,醋心。并以姜盐同煎,入疏气药良。《纲目》:降逆气,消肌肤中水气浮肿,脚气壅逆,瘴疟痞满,胎气恶阻胀闷。《本草再新》:泻肺,和胃气,利湿追风,宽肠消肿,理腰脚气,治疟疾泻痢。
黄连清热燥湿,泻火解毒。用于湿热痞满,呕吐吞酸,泻痢,黄疸,高热神昏,心火亢盛,心烦不寐,血热吐衄,目赤,牙痛,消渴,痈肿疔疮;外治湿疹,湿疮,耳道流脓。酒黄连善清上焦火热。用于目赤,口疮。姜黄连清胃和胃止呕。用于寒热互结,湿热中阻,痞满呕吐。萸黄连舒肝和胃止呕。用于肝胃不和,呕吐吞酸。用于湿热内蕴、肠胃湿热、呕吐、泻痢等症。配黄芩、大黄等,能治湿热内蕴之证。对湿热留恋肠胃,常配合半夏、竹茹;配木香、黄芩、葛根等以治泻痢。
厚朴苦,辛,温。归脾、胃、肺、大肠经。功效燥湿消痰,下气除满。湿阻中焦,脘腹胀满。本品苦燥辛散,能燥湿,又下气除胀满,为消除胀满的要药。常与苍术、陈皮等同用,如平胃散(《和剂局方》)食积气滞,腹胀便秘。本品可下气宽中,消积导滞。常与大黄、枳实同用,如厚朴三物汤(《金匮要略》)。若热结便秘者,配大黄、芒硝、枳实,以达峻下热结,消积导滞之效,即大承气汤(《伤寒论》)。
炒芡实固肾涩精,补脾止泄。治遗精,淋浊,带下,小便不禁,大便泄泻。健脾止泻:用于脾虚泄泻,常配山药、白术补中益气,为滋养强壮性食物,和莲子有些相似,但芡实的收敛固精作用比莲子强,适用于慢性泄泻和小便频数,梦遗滑精,妇女带多腰酸等。慢性泄泻,包括慢性肠结核,五更泄泻等。《本草从新》:补脾固肾,助气涩精。
五味子温;酸、甘;归肺、心、肾经。收敛固涩,益气生津,补肾宁心。用于久嗽虚喘,梦遗滑精,遗尿尿频,久泻不止,自汗,盗汗,津伤口渴,短气脉虚,内热消渴,心悸失眠。果实作中药功能益气生津、敛肺滋肾、止泻、涩精、安神,可治久咳虚喘、津少口干、遗精久泻、健忘失眠等症。五味子果实作中药功能益气生津、敛肺滋肾、止泻、涩精、安神,可治久咳虚喘、津少口干、遗精久泻、健忘失眠等症。药理试验证明能调节中枢神经系统的兴奋和抑制过程,促进肌体代谢,调节胃液和胆液分泌,对肝炎恢复期转氨酶升高者有降低作用。《本草汇言》:五味子,敛气生津之药也。故《唐本草》主收敛肺虚久嗽耗散之气。凡气虚喘急,咳逆劳损,精神不足,脉势空虚,或劳伤阳气,肢体赢瘦,或虚气上乘,自汗频来,或精元耗竭,阴虚火炎,或亡阴亡阳,神散脉脱,以五味子治之,咸用其酸敛生津,保固元气而无遗泄也。然在上入肺,在下入肾,入肺有生津济源之益,入肾有固精养髓之功。
白术味苦、甘,温。归脾、胃经。主治健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。《药性论》载其:君,味甘,辛,无毒。能主大风痹,多年气痢,心腹胀痛,破消宿食,开胃,去痰涎,除寒热,止下泄。主面光悦,驻颜,去黑。治水肿胀满,吐呕逆,腹内冷痛,吐泻不住,及胃气虚冷痢。
山药味甘、性平,入肺、脾、肾经;不燥不腻,有健脾补肺、益胃补肾、固肾益精、聪耳明目、助五脏、强筋骨、长志安神、延年益寿的功效;主治脾胃虚弱、倦怠无力、食欲不振、久泄久痢、肺气虚燥、痰喘咳嗽、肾气亏耗、腰膝酸软、下肢痿弱、消渴尿频、遗精早泄、带下白浊、皮肤赤肿、肥胖等病症。《本草纲目》概括五大功用“益肾气,健脾胃,止泄痢,化痰涎,润皮”。山药煮粥或者用冰糖煨熟后服用,对身体差、肠炎、肾亏等慢性病均有疗效。补益脾胃:治疗脾胃虚弱、泄泻、体倦、食少、虚汗。益肺滋肾:本品不寒不燥,味甘质润,可治疗肺肾虚损的消渴、遗精、带下等病证。被誉为神仙药。
陈皮温;辛、苦;归脾、肺经陈皮的苦味物质是以柠檬苷和苦味素为代表的“类柠檬苦素”,这种类柠檬苦素味平和,易溶解于水,有助于食物的消化。陈皮用于烹制菜肴时。其苦味与其他味道相互调和,可形成独具一格的风味。陈皮含有挥发油、橙皮甙、维生素B、C等成分,它所含的挥发油对胃肠道有温和刺激作用,可促进消化液的分泌,排除肠管内积气,增加食欲。陈皮也是一味常用中药,具有通气的健脾、燥湿化痰、解腻留香、降逆止呕的功效。
肉豆蔻(学名Myristica fragrans Houtt.)收涩药;温里药;行气药。性辛味苦,温。归脾;胃;大肠经。功效主治温中涩肠;行气消食。用于虚泻;冷痢;脘腹胀痛;食少呕吐;宿食不消。《日华子本草》:调中,下气,止泻痢,开胃,消食。皮外络,下气,解酒毒,治霍乱。《开宝本草》:温中,治积冷心腹胀痛,霍乱中恶,呕沫,冷气,消食止泄,小儿乳霍。《纲目》:暖脾胃,固大肠。
枳壳苦、辛、酸,温。归脾、胃经。功能理气宽中,行滞消胀。用于胸胁气滞,胀满疼痛,食积不化,痰饮内停;胃下垂,脱肛,子官脱垂。《本草经疏》:枳壳,气味所主,与枳实大略相同。但枳实形小,其气全,其性烈,故善下达;枳壳形大,其气散,其性缓,故其行稍迟,是以能人胸膈肺胃之分及入大肠也。其主风痒麻痹,通利关节,止风痛者,盖肺主皮毛,胃主肌肉,风寒湿入于二经,则皮肤瘙痒,或作痛,或麻木,此药有苦泄辛散之功,兼能引诸风药入于二脏,故为治风所需,风邪既散,则节自然通利矣。其疗劳气咳嗽,背膊闷倦者,盖亦指风寒郁于上焦,则肺气滞而为闷倦咳嗽。
葛根解表退热,生津,透疹,升阳止泻。用于外感发热头痛、高血压颈项强痛、口渴、消渴、麻疹不透、热痢、泄泻。《本草纲目》载:葛根,性凉、气平、味甘,具清热、降火、排毒诸功效。现代医学研究表明:葛根中的异黄酮类化合物葛根素对高血压、高血脂、高血糖和心脑血管疾病有一定疗效。升举阳气,止渴止泻葛根轻清升散,药性升发,柳举阳气,鼓舞机体正气上升,津液布行。升发脾胃清阳空气而止渴,止泻痢。故常用于治疗内热消渴,麻疹透发不畅,腹泻、痢疾等病症。
地丁,为堇菜科植物紫花地丁、犁头草;豆科植物米口袋、小米口袋或龙胆科植物华南龙胆的带根全草(上述这些药草的药性相似,在中药领域通称地丁,可以混用,在本发明中亦药性相似,可以混用)。可以清热利湿,解毒消肿。治疔疮,痈肿,瘰疬,黄疸,痢疾,腹泻,目赤,喉痹,毒蛇咬伤。《滇南本草》:破血,解痈疽疥癞,九种痔疮,诸疮毒症。《纲目》:主治一切痈疽发背,疔肿瘰疬,无名肿毒,恶疮。《本草求原》:凉血,消肿毒。治血热筋痿,敷疮妙。《岭南采药录》:作泻药及吐药。《上海常用中草药》:清热解毒,外用拔毒消肿。治目赤肿痛,麦粒肿,疗疮肿毒,乳痈,肠炎腹泻,毒蛇咬伤。
焦三仙是三味药,即焦麦芽、焦山楂、焦神曲。这三味药均有良好的消积化滞功能,但又有各自不同的特点。焦麦芽有很好的消化淀粉类食物的作用;焦山楂善于治疗肉类或油腻过多所致的食滞;焦神曲则利于消化米面食物。三药合用,能明显地增强消化功能。因此,临床上医生常将三药合用并称为“焦三仙”。
麦芽,经大麦发芽而成,将麦芽置锅内微炒至黄色,喷洒清水,取出晒干,即为焦麦芽。焦麦芽具有健脾和胃、舒肝化滞之功,用于治疗食积不消、脘腹胀满、食欲不振、呕吐泄泻等症。现代研究认为,麦芽中富含淀粉分解酶、转化糖酶、脂化酶、维生素B等,有良好的助消化作用。
山楂,切片晒干,置锅内用武大炒至外面焦褐色、内部黄褐色为度、喷洒清水,取出晒干,即为焦山楂。口服山楂能增加消化酶,促进脂肪的分解和消化,对因吃肉类或油腻过多所致脘腹胀满、嗳气、不思饮食、腹痛、腹泻者,疗效尤佳。此外,现代药物试验表明,山楂有缓慢而持久的降低血压的功效,还可降低胆固醇和甘油三酯,防止动脉粥样硬化,而且还可舒张冠状动脉,增加心肌收缩力,对抗心律失常。因此,有利于防治高血压、高血脂、动脉硬化及冠心病。
神曲,为全麦粉和其他药物(青蒿、苍耳,辣蓼、杏仁、赤小豆等芽)混合后经发酵而成的加工品。取神曲置锅内炒至外表呈焦黑色、内部焦黄色,取出,喷洒些消水,放凉,即为焦神曲。神曲经发酵而成,凡发酵之品都有健脾胃助消化的作用,因此,对于饮食内伤所致的消化的不良、胸痞腹胀颇有效验。
鸡内金甘,寒。归脾、胃、小肠、膀胱经。消食健胃,涩精止遗。鸡内金含胃激素、角蛋白、氨基酸以及微量胃蛋白酶、淀粉酶等。口服鸡内金粉后,胃液的分泌量、酸度和消化力均增高,胃运动加强、排空加快。其酸提取液或煎剂能加速从尿中排除放射性锶。
茯苓甘、淡,平。归心、肺、脾、肾经。功能利水渗湿,健脾宁心。用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠。渗湿利水,益脾和胃,宁心安神。治小便不利,水肿胀满,痰饮咳逆,呕哕,泄泻,遗精,淋浊,惊悸,健忘。《本经》载其:″主胸胁逆气,忧恚惊邪恐悸,心下结痛,寒热烦满,咳逆,口焦舌干,利小便。″《别录》:″止消渴,好睡,大腹,淋沥,膈中痰水,水肿淋结。开胸腑,调脏气,伐肾邪,长阴,益气力,保神守中。″《药性论》:″开胃,止呕逆,善安心神。主肺痿痰壅。治小儿惊痫,心腹胀满,妇人热淋。″
菟丝子甘辛平,入肝、肾经。补肾益精,养肝明目,安胎。用于肝肾亏虚,腰膝酸痛,阳痿遗精,尿频遗尿,两目昏暗,胎动不安等症。功能滋补肝肾,固精缩尿,安胎,明目,止泻。用于阳痿遗精、尿有余沥、遗尿尿频、腰膝酸软、目昏耳鸣、肾虚胎漏、胎动不安、脾肾虚泻。
肉桂性大热,味辛、甘。是补火助阳,引火归源,散寒止痛,活血通经的良药。用于阳痿、宫冷、心腹冷痛、虚寒吐泻、经闭、痛经、温经通脉。主治肾阳不足;命门火畏寒肢冷;腰膝酸软;阳痿遗精;小便不利或频数;短气喘促;浮肿尿少诸证;命门火衰;火不归源;戴阳;格阳;及上热下寒;面赤足冷;头晕耳鸣;口舌糜破;脾肾虚寒;脘腹冷痛;食减便溏;肾虚腰痛;寒湿痹痛;寒疝疼痛;宫冷不孕;痛经经闭;产后瘀滞腹痛;阴疽流注;或虚寒痈疡脓成不溃;或溃后不敛。《别录》载其:主心痛,胁风,胁痛,温筋,通脉,止烦、出汗。主温中,利肝肺气,心腹寒热、冷疾,霍乱转筋,头痛,腰痛,止唾,咳嗽;能堕胎,坚骨节,通血脉,理疏不足;宣导百药,无所畏。
熟地黄甘,微温。归肝、肾经。功能主治滋阴补血,益精填髓。用于肝肾阴虚,腰膝酸软,骨蒸潮热,盗汗遗精,内热消渴,血虚萎黄,心悸怔忡,月经不调,崩漏下血,眩晕,耳鸣,须发早白。《纲目》载其:“填骨髓,长肌肉,生精血。补五脏内伤不足,通血脉,利耳目,黑须发,男子五劳七伤,女子伤中胞漏,经候不调,胎产百病。”
白芍入肝、脾经,养血柔肝,缓中止痛,敛阴收汗。治胸腹胁肋疼痛,泻痢腹痛,自汗盗汗,阴虚发热,月经不调,崩漏,带下,妇人血闭不通,消瘀血,能蚀脓,益女子血。《日华子本草》:治风、补劳,主女人一切病,并产前后诸疾,通月水,退热,除烦,益气,天行热疾,瘟瘴,惊狂,妇人血运,及肠风,泻血,痔瘘。发背,疮疥,头痛,明目,目赤努肉。赤色者多补气,白者治血。
防风味辛、甘,性微温。归膀胱、肝、脾经。祛风解表,胜湿止痛,止痉。主治外感表证,风疹瘙痒,风湿痹痛,破伤风。常配合羌活、桂枝、姜黄防风能升脾阳而止泻。临床常见有因脾胃之虚,怠惰嗜卧,肢体酸疼,大便溏泄,小溲频数者,用升阳益胃汤(《脾胃论》),每奏捷效。若因外伤风邪,肝木乘脾,完谷不化,而泄泻者,用痛泻要方(《医方集解》引刘草窗方),取防风能舒脾泻肝胜湿,为引经之要药。防风配枳实(壳)能通便。方如《太平圣惠方》搜风顺气丸用防风升脾之清气,配枳壳、大黄以宽肠顺气,治中风而引起的风秘、气秘,使清阳升而浊阴降。王好古用防风合苍术、甘草为末(神术散),加生姜、葱白煎服,治内伤冷饮,外感寒邪而无汗者。临床取本方加枳壳(实)、麦芽治心下虚痞,以行气除满,消食去滞。
本发明蜜炼丸剂的制作过程为:白头翁1000g,山药1000g,炒芡实1000g,马齿苋500g,云木香1000g,肉豆蔻1000g,白术1000g,茯苓1000g,地丁1000g,薤白1000g,大腹皮1000g,黄连500g,陈皮1000g。
把药材加水浸泡30分钟至1小时,加热煮沸30分钟,过滤,滤液备用;滤渣加水,第二次加热,煮沸30分钟,再过滤,滤液备用;滤渣再加水,第三次加热煮沸30分钟,过滤;将三次滤液合在一起,加热浓缩至糊状,放入烘箱,控制在75℃,烘干后冷却成粉末状与蜂蜜适量混和在一起搓成细条;以每5g为一丸腊封包装。
本发明当腰痛、畏寒、少腹冷痛、晨起即泻明显者时胶囊剂的制作过程为:取白头翁1000g,山药1000g,炒芡实1000g,马齿苋500g,云木香1000g,肉豆蔻1000g,白术1000g,茯苓1000g,地丁1000g,薤白1000g,大腹皮1000g,黄连500g,陈皮1000g,肉桂1000g,菟丝子1000g,五味子1000g,熟地1000g加入5-10倍量的水浸泡1-2小时,提取2次;加热提取1-2小时,浓缩至浸膏状,成为组分1;剩余药渣加60-90%乙醇浸泡0.5-1.5小时,提取两次,每次1-2小时,合并提取液,滤过,浓缩,80-160目滤过,6000-10000转/分钟离心后的上清液,经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为1.35(80℃)的浸膏,加热回流提取2次,每次30分钟~45分钟,提取活性成份,将2次提取液合并静置成浸膏状,作为组分2。将上述两种浸膏浓缩干燥成干膏,混合粉碎,加淀粉适量,混匀,灌装胶囊
本发明伴明显腹痛、腹胀,泻后痛减时胶囊剂的制备过程包括:取白头翁1000g,山药1000g,炒芡实1000g,马齿苋500g,云木香1000g,肉豆蔻1000g,白术1000g,茯苓1000g,地丁1000g,薤白1000g,大腹皮1000g,黄连500g,陈皮1000g,厚朴1000g,枳壳1000g,白芍1000g,葛根1000g,防风1000g,
先将药材放入10倍量乙醇中,加热回流提取2次,每次45分钟,提取活性成份,将2次提取液合并静置。再将药渣加10倍量水,加热回流提取3次,每次1小时,将3次提取液合并;合并上述两种提取液,减压回收乙醇并浓缩至药液浓度为0.5g生药/mL,抽滤后,滤液的相对密度约为1.06(20℃);上述滤液经体积为10L的大孔吸附树脂柱,先用10倍树脂柱体积的去离子水或蒸馏水洗脱,再用5倍树脂柱体积的95%乙醇洗脱,收集乙醇洗脱液,去除溶剂,得到组份药;装入胶囊制为胶囊剂,每粒胶囊装0.3g。可以每12粒为一版。
本发明当症见纳差不食、食而不化者时作为粉剂中成药的制作过程为:取焦三仙各1000g,鸡内金500g,白头翁1000g,山药1000g,炒芡实1000g,马齿苋500g,云木香1000g,肉豆蔻1000g,白术1000g,茯苓1000g,地丁1000g,薤白1000g,大腹皮1000g,黄连500g,陈皮1000g,所述组份按配比混合,投入粉碎机粉碎成细粉,细粉过筛后放入耐酸碱浸渍锅内,在常温下,与乙醇共同浸渍10~20天,将浸渍好的液体及药渣进行压榨过滤,分离后取滤液,加热浓缩至糊状,放入烘箱,控制在100℃,烘干后冷却,粉碎后以每袋4~6g包装。
药理药效学实验:
1、急性毒性试验
应用小鼠进行急性毒性实验表明:小鼠口服灌胃本发明的中药制剂胶囊剂,在488.8g生药/kg剂量下,给药后小鼠出现轻微活动减少,1小时左右恢复正常,给药后连续观察7天,无一动物死亡,其全身状况、饮食、摄水、小便和体重增长均正常,实验结果表明:小鼠口服灌胃本发明的中药制剂胶囊剂的最大给药量为488.8g生药/kg/d(LD 50>488.8g生药/kg)。本发明的中药制剂每日临床用药总量为0.1g生药/kg/d;按体重计,小鼠灌胃本发明的中药制剂的耐受量为临床病人的4888倍。提示该药急性毒性低,临床用药安全。
2、长期毒性试验
选用SD大鼠,给予不同浓度(18.0、6.0、2.0g生药/kg)的本发明的中药制剂丸剂,每天灌胃一次,连续90天,末次给药后24小时各组活杀1/2动物(雌雄各半),其余1/2动物继续观察2周后活杀。试验期间观察动物的外观、一般行为、摄食量、体重变化,给药后90天和停药2周进行血液学(RBC、HB、网织红细胞、PLT、CT、WBC及分类)和血液生化(AST、ALT、ALP、Glu、BUN、Crea、TP、T.BIL、ALB、CHOL)、尿液生化、脏器系数、病理组织学等指标检查。试验结果表明:本发明的中药制剂在高、中、低剂量组动物一般状态良好,外观体征、行为活动、进食量和体重增长均无异常变化;三个剂量组及对照组血液学检查、血液生化学、尿液生化检查均在正常范围,组间无显著差异;各组主要脏器组织病理学检查未见明显异常。上述指标停药2周后也未见改变。本试验用药剂量分别为临床用药剂量的180、60、20倍,根据试验结果本发明的中药制剂在高、中、低三个剂量(18.0、6.0、2.0g生药/kg)连续90天给药对大鼠无明显影响,无明确的毒性靶器官和敏感指标,恢复期观察也未见延迟性毒性反应,提示本发明的中药制剂临床应用的剂量安全性较高。
3、选用SD大鼠,给予不同浓度(18.0、6.0、2.0g生药/kg)的本发明的中药制剂,每天灌胃一次,连续90天,末次给药后24小时各组活杀1/2动物(雌雄各半),其余1/2动物继续观察2周后活杀。试验期间观察动物的外观、一般行为、摄食量、体重变化,给药后90天和停药2周进行血液学(RBC、HB、网织红细胞、PLT、CT、WBC及分类)和血液生化(AST、ALT、ALP、Glu、BUN、Crea、TP、T.BIL、ALB、CHOL)、尿液生化、脏器系数、病理组织学等指标检查。试验结果表明:本发明的中药制剂在高、中、低剂量组动物一般状态良好,外观体征、行为活动、进食量和体重增长均无异常变化;三个剂量组及对照组血液学检查、血液生化学、尿液生化检查均在正常范围,组间无显著差异;各组主要脏器组织病理学检查未见明显异常。上述指标停药2周后也未见改变。本试验用药剂量分别为临床用药剂量的180、60、20倍,根据试验结果本发明的中药制剂在高、中、低三个剂量(18.0、6.0、2.0g生药/kg)连续90天给药对大鼠无明显影响,无明确的毒性靶器官和敏感指标,恢复期观察也未见延迟性毒性反应,提示本发明的中药制剂临床应用的剂量安全性较高。
药效学实验
一、本发明中药制剂的蜜丸剂对正常小鼠小肠运动的影响
1试验材料
1.1试验动物:由中国医学科学院放射医学研究所购入ICR小鼠50只,雌雄各半,体重18~20g,动物许可证号:SCXK津2005-0001。
1.2试验药物:
1.2.1本发明中药制剂的蜜丸剂。将本发明中药制剂的蜜丸剂用蒸留水配制成0.467、0.233、0.117g生药/ml的蜜丸剂混悬液待用。
1.2.2硫酸阿托品注射液(河南省新乡市常乐制药厂,H41020226),使用前用生理盐水稀释成0.01mg/ml溶液。
1.2.3活性炭;阿拉伯胶(制成含10%阿拉伯树胶,5%活性炭的炭末蒸馏水混悬液)。
1.3试验设备:T-500电子天平(常熟双杰测试仪器厂,编号:256),PL203精密电子天平。
2试验方法
选用18~20g体重小鼠,按体重随机分层的方法分为5组,即空白对照组、阳性药(阿托品)组、本发明中药制剂的蜜丸剂高、中、低剂量组。每组10只,雌雄各半。空白对照组和阿托品组灌胃蒸馏水30ml/kg,高、中、低剂量组分别灌胃本发明中药制剂的蜜丸剂混悬液14、7、3.5g生药/kg,1次/d。灌胃7天后,于实验前一天傍晚禁食不禁水18h,于第8天末次给药1h(阿托品稀释液0.1mg/kg 5min)后,各组灌胃炭末混悬液0.2ml/只。20min后处死动物,打开腹腔分离肠系膜,剪取前端至幽门,后端至回盲部的肠管,置于托盘上。轻轻将小肠摆成直线,测量肠管长度作为“小肠总长度”。从幽门至墨汁前沿的距离作为“墨汁在肠内推进的距离”。公式计算墨汁推进率:墨汁推进率=(墨汁在肠内推进距离/小肠全长)×100%。
3试验结果
与对照组比较,阳性药阿托品组炭末前沿推进率明显减少(P<0.05),本发明中药制剂的蜜丸剂3.5g生药/kg组有一定的使炭末前沿推进率明显减少作用,但随剂量增高,则使炭末前沿推进率加大,并与剂量相关的呈高于对照组的趋势,但无统计学意义。见表1
表1本发明中药制剂的蜜丸剂对小鼠小肠运动的影响
组别 | 例数 | 前沿推进率% |
正常对照组 | 10 | 64.78±9.36 |
模型对照组 | 10 | 72.45±8.716 |
阿托品组 | 10 | 43.41±14.22** |
本发明蜜丸剂3.5g生药/kg | 10 | 57.45±16.91 |
本发明蜜丸剂7g生药/kg | 10 | 78.81±17.29 |
本发明蜜丸剂14g生药/kg | 10 | 82.39±15.32 |
注:与正常对照组比较:**P<0.01。
4试验结论
与正常对照组比较,本发明中药制剂的蜜丸剂3.5g生药/kg有一定抑制正常小鼠小肠运动作用;7-14g生药/kg灌胃给药,随剂量增加而表现有促进正常小鼠小肠炭末推进的趋势,但均无明显的统计学意义。
二、本发明中药制剂的蜜丸剂对运动机能亢进小鼠小肠运动的影响
1、新斯的明注射液(上海信宜金朱药业有限公司生产,批号060204),使用前用生理盐水稀释成0.01mg/ml稀释液。
2、小鼠按体重随机分层的方法分为5组,即空白对照组、模型组对照、阳性药(阿托品)组、本发明中药制剂的蜜丸剂高、中、低剂量组。每组10只,雌雄各半。空白对照组、模型对照组和阿托品组灌胃蒸馏水30ml/kg,高、中、低剂量组分别灌胃本发明中药制剂的蜜丸剂混悬液14、7、3.5g生药/kg,1次/d。灌胃7天后,于实验前一天傍晚禁食不禁水18h,于第8天末次给药1h后,除空白对照组外,其余各组均sc新斯的明溶液0.1mg/10ml/kg(阿托品稀释液0.1mg/10ml/kg),5min后各组灌胃炭末混悬液0.2ml/只。20min后处死动物,打开腹腔分离肠系膜,剪取小肠前端至幽门,后端至回盲部的肠管,置于托盘上。轻轻将小肠摆成直线,测量肠管长度作为“小肠总长度”。从幽门至墨汁前沿的距离作为“墨汁在肠内推进的距离”。用公式计算墨汁推进率为:墨汁推进率=(墨汁在肠内推进距离/小肠全长)×100%
3、试验结果
与空白对照组比较,模型对照组小肠推进明显亢进,说明新斯的明致小鼠小肠推进亢进模型复制成功。与模型对照组比较,阿托品组与低剂量组能够明显抑制肠运动功能亢进小鼠的炭末前沿推进率(分别p<0.01和p<0.05);高剂量组有促进小肠推进的趋势,但无统计学意义。见表2。
表2本发明中药制剂的蜜丸剂对小肠推进亢进小鼠小肠运动的影响
组别 | 例数 | 前沿推进率% |
正常对照组 | 10 | 65.78±7.36 |
模型对照组 | 10 | 71.45±5.716△ |
阿托品组 | 10 | 42.41±12.22*** |
本发明蜜丸剂3.5g生药/kg | 10 | 65.45±14.91** |
本发明蜜丸剂7g生药/kg | 10 | 69.11±15.29 |
本发明蜜丸剂14g生药/kg | 10 | 84.39±12.32 |
注:与正常对照组比较:△P<0.05,与模型对照组比较:**P<0.01,***P<0.001。
试验结论:本发明中药制剂的蜜丸剂3.5g/kg对肠运动功能亢进小鼠小肠运动有明显抑制作用,随剂量增加,表现出促进肠运动作用的趋势。本试验从对在体和离体肠道功能影响、止泄、抑菌、抗炎抗免疫等方面研究了本发明中药制剂的蜜丸剂治疗肠炎、痢疾的药理作用机理,试验结果表明,本发明中药制剂的蜜丸剂虽不是通过直接抑制小肠推进达到止泄作用,但其能促进肠道消化、吸收,并有一定抑菌作用,且表现出较强的抗炎抗免疫作用。
三、本发明中药制剂的蜜丸剂对正常大鼠尿液中木糖和淀粉酶的影响
1试验材料
1.1试验动物:由北京维通利华实验动物技术有限公司购入wistar大鼠60只,雌雄各半,体重130~145g,动物许可证号:SCXK(京)2007-0001。
1.2试验药物:
1.2.1本发明中药制剂的蜜丸剂:每g药粉含2g提取物,将本发明中药制剂的蜜丸剂用蒸馏水配制成0.6、0.3、0.15g生药/ml的混悬液待用。
1.2.2思密达(博福益普生天津制药有限公司,批号S0120),用蒸馏水配制成0.3g/ml混悬液待用。
1.2.3D-木糖(天津市光复精细化工研究所,批号20070712),用蒸馏水配制成10%D-木糖溶液待用。
1.2.4淀粉酶试剂盒(由南京建成生物工程研究所提供,批号20070525);D-木糖试剂盒(由南京建成生物工程研究所提供,批号20070525)。
1.3试验设备:T-1000电子天平(常熟双杰测试仪器厂,编号3265);大鼠代谢笼;紫外分光光度计。
2试验方法
大鼠按体重分层随机的方法分为5组,即空白对照组、阳性药组、本发明中药制剂的蜜丸剂高、中、低剂量组。每组10只,雌雄各半。高、中、低剂量组分别灌胃本发明中药制剂的蜜丸剂混悬液6、3、1.5g生药/kg灌胃相应剂量的混悬液10ml/kg,阳性药组灌服同体积盐酸思密达溶液,空白对照组灌胃蒸馏水,1次/d。连续给药2d后,于实验前一天傍晚禁食不禁水18h,转天末次给药1h后,按摩大鼠腹部以排空膀胱内储尿,每只大鼠灌服10%D-木糖溶液5mL,放入代谢笼中,收集5h尿液。测定尿中木糖和淀粉酶含量。
3试验结果
本发明中药制剂的蜜丸剂6g/kg组尿淀粉酶活性和D-木糖排泄量与对照组比、较明显升高,数据见表3。
表3本发明中药制剂的蜜丸剂对正常大鼠木糖和淀粉酶含量的影响
组别 | 例数 | 5h尿木糖含量(g) | 淀粉酶含量 |
正常对照组 | 10 | 8.52±1.65 | 3896.78±2132.36 |
思密达组 | 10 | 13.72±4.96** | 3234.78±1317.64 |
本发明蜜丸剂1.5g生药/kg | 10 | 11.02±4.87 | 3576.13±1532.76 |
本发明蜜丸剂3g生药/kg | 10 | 10.42±3.92 | 4496.78±1798.96 |
本发明蜜丸剂6g生药/kg | 10 | 12.72±2.76* | 7893.78±2612.37*** |
注:与对照组比较:*P<0.05,**P<0.01,***P<0.001。
4试验结论:
淀粉酶活性测定和木糖吸收试验是较公认的反映肠道消化、吸收功能的指标。淀粉酶是人体消化过程的一种重要消化酶,分泌不足会影响食物消化,本实验结果表明,本发明中药制剂的蜜丸剂能增强淀粉酶活性,有助于人体消化功能的提高。D-木糖内服后主要由十二指肠与空肠经易化扩散而吸收,因其为单糖,在吸收前没有先行消化、分解的必要,吸收后也不被肝脏和周围组织所代谢,加之其水溶性,可大部分以原型从尿中排出,故可借口服定量木糖后从尿中排出量来测知小肠的吸收功能。本实验结果表明,本发明中药制剂的蜜丸剂能够提高肠消化吸收功能。
四、本发明中药制剂的蜜丸剂对脾虚小鼠腹泻的影响
1试验材料
1.1试验动物:由中国医学科学院放射医学研究所购入ICR小鼠72只,雌雄各半,体重18~20g,动物许可证号:SCXK津2005-0001。
1.2试验药物
1.2.1本发明中药制剂的蜜丸剂:每g药粉含2g
提取物,将本发明中药制剂的蜜丸剂用蒸馏水配制成0.467、0.233、0.117g生药/ml的本发明中药制剂的蜜丸剂混悬液待用。
1.2.2黄连素水(盐酸小檗碱),注意除去糖衣,精密称定,研细,精密称取适量(约相当于盐酸小檗碱0.3g),置烧杯中,加蒸馏水配制成10%水混悬液待用。
1.2.3香砂六君丸(天津中新药业集团有限公司乐仁堂制药厂生产,批号A118008)。
1.3试验设备:T-500电子天平(常熟双杰测试仪器厂,编号:256),PL203精密电子天平(梅特勒-托利多仪器(上海)有限公司制造)。
2试验方法
小鼠按体重分层随机的方法分为6组,即空白对照组、模型对照组、阳性药组、本发明中药制剂的蜜丸剂高、中、低剂量组,每组12只。动物随机分组后,除空白对照组外,其余各组每天灌服10%黄连素水混悬液0.5ml/只,给药7d后动物出现食欲减退、活动减少、泄泻、竖毛拱背、毛色失泽等脾虚症状。后每日继续灌服黄连素水混悬液0.5ml/只,1h后本发明中药制剂的蜜丸剂组分别灌胃本发明中药制剂的蜜丸剂混悬液14、7、3.5g生药/kg,给药体积为30ml/kg,空白对照组和模型组灌服同体积蒸馏水。按此方法给药3d后,傍晚各组动物禁食不禁水。转日晨起同前法给药,给药1h后,灌胃黄连素水混悬液0.5ml/只(空白对照组给予同体积蒸馏水)。各小鼠分别置于垫有洁净滤纸的鼠笼内,1h更换垫纸一次,观察并记录6h湿粪粒数,并经SPSS11.5统计软件统计。
3试验结果
排便4h内,模型组稀粪粒数比对照组明显增多,说明脾虚模型成功,本发明中药制剂的蜜丸剂三个剂量组湿粪粒数均高于模型组,未显示止泻作用。而在排便第4~6h之间,本发明中药制剂的蜜丸剂三个剂量组与模型对照组比较,湿粪粒数明显减少(P<0.05)。数据见表4~5。
表4本发明中药制剂的蜜丸剂对脾虚泄泻小鼠稀粪粒数的影响
注:与正常对照组比较:△P<0.05,△△△P<0.001,与模型组比较:*P<0.05。
表5本发明中药制剂的蜜丸剂对脾虚泄泻小鼠稀粪粒数的影响
注:与正常对照组比较:△P<0.05,△△△P<0.001。与模型组比较:*P<0.05。
4试验结论:本发明中药制剂的蜜丸剂在泄泻初期并不表现单纯止泄作用,反而促进湿粪排出,但服用本发明中药制剂的蜜丸剂后排湿粪症状缓解时间较模型组提前,从而达到止泄作用。
具体实施例:
实施例1:龚某,男,39岁。诊诉腹痛、泄泻,反复发作5年左右,多因受凉或饮食生冷而加重,曾多次静滴、口服抗生素未见明显好转(具体用药情况不详),刻下症见左下腹隐痛,大便溏薄,带白色粘液,偶有大便带血,每日3~5次,黎明则泄,常伴腰酸,腹胀,肠鸣,纳差,神疲乏力,面色晦暗,形瘦体弱,舌淡黯红,苔白,脉沉细弦。乙状结肠镜检查:肠道20~25cm处大量粘液,21cm处见一针头大出血点,周围粘膜明显充血水肿。18cm处见芝麻大出血点。18cm~20cm处粘膜充血肿胀,呈花斑样改变,粘液涂片未见异常。大便培养无细菌生长。用以下药物治疗:白头翁10g,山药10g,炒芡实15g,马齿苋5g,云木香10g,肉豆蔻10g,白术10g,茯苓10g,地丁10g,薤白10g,大腹皮10g,黄连5g,陈皮10g,肉桂10g,菟丝子10g,五味子10g,熟地10g,焦三仙10g,鸡内金10g。
以中药汤剂服用,连服两个疗程起效,腹痛止,便血止,开始食欲正常,连服三个月痊愈,随访无复发。
实施例2:方陈某,男,28岁。症状:午后肠鸣辘辘1月,前投苓桂术甘汤初有效,但停药又起,大便质烂,每日1~2次,肝区胀痛,嗳气,舌红,苔薄黄,脉细弦。辩证:肠鸣大便烂,以强脾胃而抑肝,理顺肝脾(胃)关系。用以下药物治疗:白头翁10g,山药10g,炒芡实15g,马齿苋5g,云木香10g,肉豆蔻10g,白术10g,茯苓10g,地丁10g,薤白10g,大腹皮10g,黄连5g,陈皮10g,枳壳10g,白芍10g,厚朴10g,葛根10g,防风10g。回访:服药后肠鸣消失,余症均减。
实施例3:秦某,女,29岁。症状:脐周腹痛则欲解大便,便后痛减,每日如此者三,大便不成形,夹黏冻及不消化食物,肠鸣,纳呆,舌淡红,苔薄黄腻,脉细弦。辩证:化肠间之饮,患者大便次数本多,故弃大黄不用;健脾化湿,因饮由湿生,故用白术、茯苓、山药健脾化湿以杜饮之渐;消食和胃,因患者纳呆、大便含不消化食物,故用神曲、麦芽、焦山楂消食;缓急止痛,清化湿热。用以下药物治疗:白头翁10g,山药10g,炒芡实15g,马齿苋5g,云木香10g,肉豆蔻10g,白术10g,茯苓10g,地丁10g,薤白10g,大腹皮10g,黄连5g,陈皮10g,焦三仙各10g,鸡内金10g,连服两个疗程。回访:服药第3剂后,大便1日1次,成形,黏液减少,无不消化物,无腹痛,无肠鸣,再予7剂以资巩固。
实施例4陈某,男,45岁,因腹部不适,肠鸣腹泻二十余日入院,因尿中泡沫增多,尿中有蛋白,在当地医院查血肌肝(SCR):179μmol/l,尿素氮(BUN):8.3mmol/l。B超示右肾缩小,内有结石,皮髓质分界不清,皮质变薄,回声增强,后复查尿蛋白一直半个加或阴性。否认幼时浮肿史,否认高血压史,否认肝炎,伤寒,结核病病史,否认家族性肾脏病病史,无青霉素过敏史。20多天前,服中药后出现腹部不适,恶心,肠鸣即腹泻,每日25次,为黄色稀便,无粘冻脓血便,无黄疸黑便,无里急后重。入院时右肾叩击痛可疑,左侧阴性,肝右肋下可及质软,脾肋下未及。肠镜示:慢性结肠炎。诊断:间质性肾炎、慢性结肠炎。用以下药物治疗:白头翁10g,山药10g,炒芡实15g,马齿苋5g,云木香10g,肉豆蔻10g,白术10g,茯苓10g,地丁10g,薤白10g,大腹皮10g,黄连5g,陈皮10g,肉桂10g,菟丝子10g,五味子10g,熟地10g,鸡内金10g。治疗:中药煎服,连续服用3个月。结肠炎予以对症处理。3月后复查,右肾叩击痛阴性,尿中泡沫消失。
本发明的中药制剂具有平肝止痛、理气健脾、补脾肺肾、补中益气和升阳止泻的功效,主治急慢性肠炎和结肠炎,肝旺和脾胃虚弱引起的肠鸣腹泻、食少便溏、肢倦乏力、泻后痛缓和反复发作等症。且配方简单,制造成本低廉,可推广使用。
Claims (10)
1.一种治疗肠鸣腹泻的中药制剂,其特征在于,各种组份的重量份数比为:白头翁10~20份,山药10~20份,炒芡实10~20份,马齿苋10~15份,云木香10~20份,肉豆蔻10~20份,白术10~20份,茯苓10~20份,地丁10~20份,薤白10~20份,大腹皮10~20份,黄连10~15份,陈皮10~20份。
2.根据权利要求1所述治疗肠鸣腹泻的中药制剂,其特征在于,进一步包括重量份数比的下列组份:肉桂10~20份,菟丝子10~20份,五味子10~20份,熟地10~20份。
3.根据权利要求1所述治疗肠鸣腹泻的中药制剂,其特征在于,进一步包括重量份数比的下列组份:厚朴10~20份,枳壳10~20份,白芍10~20份,葛根10~20份,防风10~20份。
4.根据权利要求1所述治疗肠鸣腹泻的中药制剂,其特征在于,进一步包括重量份数比的下列组份:焦三仙各10份,鸡内金10~15份。
5.根据权利要求1~4中任何一项所述治疗肠鸣腹泻的中药制剂,其剂型为:片剂、糖衣片剂、薄膜衣片剂、肠溶衣片剂、胶囊剂、硬胶囊剂、软胶囊剂、口服液、口含剂、颗粒剂、冲剂、丸剂、散剂、膏剂、丹剂、混悬剂、溶液剂、注射剂、栓剂、软膏剂、硬膏剂、霜剂、喷雾剂、滴剂或贴剂。
6.一种如权利要求1~4中任一项所述治疗肠鸣腹泻的中药制剂的制备方法,其特征在于,所述中药制剂的剂型为胶囊剂,制备方法包括以下步骤:
a.所述组份加入水提取2次,使提取物成浸膏状,为组分一;
b.前述步骤提取后的药渣加乙醇浓缩过滤成浸膏状,为组分二;
c将上述两种浸膏浓缩干燥成干膏,混合粉碎,加淀粉适量,混匀,灌装胶囊。
7.根据权利要求6所述治疗肠鸣腹泻的中药制剂的制备方法,其特征在于,所述步骤a中,所述组份加入其重量份5-10倍量的水浸泡1-2小时,提取2次;加热提取后的溶液1-2小时,浓缩至浸膏状,成为组分一。
8.根据权利要求6所述治疗肠鸣腹泻的中药制剂的制备方法,其特征在于,所述步骤b中,前述步骤提取后的药渣加60-90%乙醇浸泡0.5-1.5小时,提取两次,每次1-2小时,合并提取液,第一次滤过,浓缩,80-160目第二次滤过,6000-10000转/分钟离心后取上清液,经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩至80℃时相对密度为1.35的浸膏,加热回流提取2次,每次30分钟~45分钟,将2次提取液合并静置成浸膏状,作为组分二。
9.一种如权利要求1~4中任一项所述治疗肠鸣腹泻的中药制剂的制备方法,其特征在于,所述中药制剂剂型为蜜丸剂,其制备方法包括:将所述组份加水浸泡30分钟至1小时,加热煮沸30~40分钟,过滤,滤液备用;滤渣加水第二次加热,煮沸30~40分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸30~40分钟,过滤;将三次滤液合在一起,加热浓缩至糊状,放入烘箱70℃~80℃烘干后冷却,烘干后冷却,与蜂蜜混在一起搓成细条;以5g为一丸腊封包装。
10.根据权利要求1~4中任一项所述治疗肠鸣腹泻的中药制剂,其特征在于:所述中药制剂为汤剂使用时,每日1剂,水煎分两次服,每7天为一疗程;所述中药制剂为丸剂、胶囊剂或片剂使用时,一日3次,每10天为一疗程。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101621379A CN101797326B (zh) | 2010-05-05 | 2010-05-05 | 一种治疗肠鸣腹泻的中药制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101621379A CN101797326B (zh) | 2010-05-05 | 2010-05-05 | 一种治疗肠鸣腹泻的中药制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101797326A true CN101797326A (zh) | 2010-08-11 |
CN101797326B CN101797326B (zh) | 2012-05-23 |
Family
ID=42593267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101621379A Expired - Fee Related CN101797326B (zh) | 2010-05-05 | 2010-05-05 | 一种治疗肠鸣腹泻的中药制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101797326B (zh) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102198261A (zh) * | 2011-05-27 | 2011-09-28 | 孔建 | 一种治疗老年慢性结肠炎的中药制剂及其制备方法 |
CN102406887A (zh) * | 2011-12-02 | 2012-04-11 | 赵明芳 | 一种用于治疗慢性泄泻的中药组合物及其制备方法 |
CN102698145A (zh) * | 2012-06-19 | 2012-10-03 | 大连民族学院 | 用于补脾止泻的中药制剂 |
CN102772781A (zh) * | 2012-08-21 | 2012-11-14 | 杨高林 | 一种治疗慢性结肠炎的中药制剂及其制备方法 |
CN103223083A (zh) * | 2013-03-27 | 2013-07-31 | 张宗升 | 中药提取物 |
CN103585506A (zh) * | 2013-11-05 | 2014-02-19 | 卢继英 | 一种治疗小儿秋季腹泻的中药灌肠剂 |
CN104383291A (zh) * | 2014-10-28 | 2015-03-04 | 王慧 | 治疗腹泻的理气和血制剂及制备方法 |
CN104623383A (zh) * | 2015-03-05 | 2015-05-20 | 于巧媛 | 一种治疗湿热型泄泻病的中药 |
CN105561111A (zh) * | 2016-03-18 | 2016-05-11 | 张传涛 | 治疗功能性腹泻的中药组合物 |
CN105561129A (zh) * | 2016-01-04 | 2016-05-11 | 四川双鑫生物科技有限公司 | 一种治疗小儿腹泻的内服药物及制备方法 |
CN114377071A (zh) * | 2022-01-06 | 2022-04-22 | 宋易昕 | 一种中药灌肠剂及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101041048A (zh) * | 2007-04-19 | 2007-09-26 | 张秀丽 | 一种内服治疗慢性肠炎的中药组合物 |
CN101199808A (zh) * | 2007-12-19 | 2008-06-18 | 牟清霞 | 一种治疗慢性肠炎的药物 |
CN101361944A (zh) * | 2008-09-28 | 2009-02-11 | 韩瑞芹 | 一种治疗小儿腹泻的中药组合物 |
-
2010
- 2010-05-05 CN CN2010101621379A patent/CN101797326B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101041048A (zh) * | 2007-04-19 | 2007-09-26 | 张秀丽 | 一种内服治疗慢性肠炎的中药组合物 |
CN101199808A (zh) * | 2007-12-19 | 2008-06-18 | 牟清霞 | 一种治疗慢性肠炎的药物 |
CN101361944A (zh) * | 2008-09-28 | 2009-02-11 | 韩瑞芹 | 一种治疗小儿腹泻的中药组合物 |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102198261B (zh) * | 2011-05-27 | 2012-08-22 | 孔建 | 一种治疗老年慢性结肠炎的中药制剂及其制备方法 |
CN102198261A (zh) * | 2011-05-27 | 2011-09-28 | 孔建 | 一种治疗老年慢性结肠炎的中药制剂及其制备方法 |
CN102406887B (zh) * | 2011-12-02 | 2013-10-30 | 赵明芳 | 一种用于治疗慢性泄泻的中药组合物及其制备方法 |
CN102406887A (zh) * | 2011-12-02 | 2012-04-11 | 赵明芳 | 一种用于治疗慢性泄泻的中药组合物及其制备方法 |
CN102698145A (zh) * | 2012-06-19 | 2012-10-03 | 大连民族学院 | 用于补脾止泻的中药制剂 |
CN102772781A (zh) * | 2012-08-21 | 2012-11-14 | 杨高林 | 一种治疗慢性结肠炎的中药制剂及其制备方法 |
CN102772781B (zh) * | 2012-08-21 | 2014-09-10 | 青岛华仁技术孵化器有限公司 | 一种治疗慢性结肠炎的中药制剂及其制备方法 |
CN103223083A (zh) * | 2013-03-27 | 2013-07-31 | 张宗升 | 中药提取物 |
CN103585506A (zh) * | 2013-11-05 | 2014-02-19 | 卢继英 | 一种治疗小儿秋季腹泻的中药灌肠剂 |
CN103585506B (zh) * | 2013-11-05 | 2016-04-06 | 卢继英 | 一种治疗小儿秋季腹泻的中药灌肠剂 |
CN104383291A (zh) * | 2014-10-28 | 2015-03-04 | 王慧 | 治疗腹泻的理气和血制剂及制备方法 |
CN104623383A (zh) * | 2015-03-05 | 2015-05-20 | 于巧媛 | 一种治疗湿热型泄泻病的中药 |
CN105561129A (zh) * | 2016-01-04 | 2016-05-11 | 四川双鑫生物科技有限公司 | 一种治疗小儿腹泻的内服药物及制备方法 |
CN105561111A (zh) * | 2016-03-18 | 2016-05-11 | 张传涛 | 治疗功能性腹泻的中药组合物 |
CN114377071A (zh) * | 2022-01-06 | 2022-04-22 | 宋易昕 | 一种中药灌肠剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101797326B (zh) | 2012-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102048933B (zh) | 一种治疗小儿腹泻的中药组合物及其制备方法 | |
CN101797326B (zh) | 一种治疗肠鸣腹泻的中药制剂及其制备方法 | |
CN103099959B (zh) | 一种治疗溃疡性结肠炎的中药制剂及其制备方法 | |
CN102205107B (zh) | 一种治疗十二指肠溃疡的中药制剂及其制备方法 | |
CN104367879A (zh) | 一种用于治疗鸡劳伤的药物组合物及其制备方法 | |
CN101972338A (zh) | 一种治疗小儿上呼吸道感染的中药制剂及其制备方法 | |
CN104873947A (zh) | 用于治疗狗急性上消化道出血的药物组合物及其制备方法 | |
CN105749179A (zh) | 治疗代谢综合征的中药组合物 | |
CN103690919A (zh) | 用于治疗仔猪缺铁性贫血的药物及其制备方法 | |
CN105920514A (zh) | 治疗代谢综合征的中药组合物 | |
CN102205108B (zh) | 一种治疗胃溃疡的中药制剂及其制备方法 | |
CN104958607A (zh) | 一种治疗妇女更年期灼口综合征的中药组合物及方法 | |
CN103041256B (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
CN105497816A (zh) | 一种治疗动脉粥样硬化的中药制剂及其制备方法 | |
CN106994141B (zh) | 一种治疗便秘的中药组合物及其制备方法 | |
CN103007145B (zh) | 一种治疗小儿轮状病毒肠炎的中药组合物及其制备方法 | |
CN103041255B (zh) | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 | |
CN105056103A (zh) | 一种辅助降血脂降胆固醇的馒头及其制备方法 | |
CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
CN103933538A (zh) | 用于治疗脾肾阳虚型肝硬化腹水的药物及其制备方法 | |
CN103520643B (zh) | 一种用于治疗糖尿病白内障的中药制剂及其制备方法 | |
CN107890521A (zh) | 一种护肝明目的中药组合物及其丸剂的制备方法 | |
CN105362682A (zh) | 一种治疗月经过少的外用药物 | |
CN103041258B (zh) | 治疗小儿呼吸道感染伴纳差不食的中药制剂 | |
CN101810751B (zh) | 一种治疗小儿肠系膜淋巴结发炎的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120523 Termination date: 20130505 |